Wisconsin AB 849: Relating to: therapeutic interchange for drug products prescribed to counteract anaphylaxis.

Status: Failed to pass pursuant to Senate Joint Resolution 1 (as of 2024-04-15)

State: Wisconsin · Session: 2023 · Bill: AB 849

Sponsors: C. Anderson, Clancy, Conley, Considine, Drake, Emerson, J. Anderson, Joers, Madison, Ohnstad, Ortiz-Velez, Ratcliff, Shankland, Sinicki, Vining

View Wisconsin AB 849 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.